Mostra el registre parcial de l'element
dc.contributor.author | Tüter, Gülay | es |
dc.contributor.author | Yerebakan, Mukaddes | es |
dc.contributor.author | Celik, Bulent | es |
dc.contributor.author | Kara, Gulsah | es |
dc.date.accessioned | 2023-06-16T08:36:49Z | |
dc.date.available | 2023-06-16T08:36:49Z | |
dc.date.issued | 2022 | es |
dc.identifier.citation | Tuter, G., Yerebakan, M., Celik, B., & Kara, G. (2022). Oral manifestations in SARS-CoV-2 infection. En Medicina Oral Patología Oral y Cirugia Bucal (pp. e330-e339). Medicina Oral, S.L. https://doi.org/10.4317/medoral.25259 | es |
dc.identifier.uri | https://hdl.handle.net/10550/88132 | |
dc.description.abstract | We aimed to evaluate the prevalence of predisposing factors and oral manifestations in SARS-CoV-2 infection. 204 SARS-CoV-2 positive patients were included in the study. Questions regarding the systemic, periodontal health, oral hygiene habits, common symptoms and, oral manifestations of COVID-19 such as oral lesions, and dry mouth were included in the survey. The Visual Analogue Scale (VAS) was used. 47.5% of individuals had various systemic diseases. Dry mouth (44.2%) and oral lesions (22.4%) were the most common oral manifestations in COVID-19 patients. Also, dry mouth had the highest VAS score. The most common oral lesion locations were buccal mucosa (15.2%) and tongue (10.8%). The majority of participants (142 patients) were affected by taste disorders. Patients who received periodontal treatment before SARS-CoV-2 infection reported fewer oral complaint and manifestations than those who did not receive periodontal therapy (p=0.032). There was no statistically significant difference between males and females on the presence of any oral manifestations, and taste disorders. Our results showed that SARS-CoV-2 could cause oral manifestations. However various predisposing factors may be part of the etiology and promote oral findings. | es |
dc.subject | quality of life | es |
dc.subject | oral health | es |
dc.subject | combined modality therapy | es |
dc.subject | treatment outcome | es |
dc.title | Oral manifestations in SARS-CoV-2 infection | es |
dc.type | journal article | es_ES |
dc.subject.unesco | UNESCO:CIENCIAS MÉDICAS | es |
dc.identifier.doi | 10.4317/medoral.25259 | es |
dc.type.hasVersion | VoR | es_ES |
dc.identifier.url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271340/ |